Analysis of health-related quality of life in patients with brain tumors prior and subsequent to radiotherapy

Health-related quality of life (HRQOL) was evaluated for a patient cohort with benign or malignant brain tumors prior and subsequent to radiotherapy. The following inclusion criteria were applied: Sufficient compliance, understanding of patient information and the existence of a brain tumor without...

Full description

Saved in:
Bibliographic Details
Published in:Oncology letters 2017-08, Vol.14 (2), p.1841-1846
Main Authors: Bitterlich, Claudia, Vordermark, Dirk
Format: Article
Language:English
Subjects:
Baldness
Brain cancer
brain tumor
Brain tumors
Care and treatment
Cognition & reasoning
Cognitive ability
glioblastoma
Health aspects
meningioma
Oncology
Patient outcomes
Patients
Quality of life
Questionnaires
Radiation therapy
Radiotherapy
Terminology
Tumors
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Health-related quality of life (HRQOL) was evaluated for a patient cohort with benign or malignant brain tumors prior and subsequent to radiotherapy. The following inclusion criteria were applied: Sufficient compliance, understanding of patient information and the existence of a brain tumor without previous radiotherapy. Patients were asked to complete the European Organization for Research and Treatment of Cancer QLQ-C30 and QLQ-BN20 questionnaires at the following times: Prior to (t0) and subsequent to (t1) radiotherapy, and at 3 (t2), 6 (t3) and 12 (t4) months following treatment. In addition, at t1 the side effects were assessed according to the Common Terminology Criteria for Adverse Events. Generally, the global QOL, a standard term describing general QOL, improved slightly (t0=49; t4=65). At t1, a significant increase in fatigue, loss of appetite and alopecia was reported. During follow-up, the symptoms experienced by the patients decreased, and the global QOL remained constant. The objectively recorded side effects of the therapy were comparable with the patient-reported outcomes.
ISSN:1792-1074
1792-1082
DOI:10.3892/ol.2017.6310